UBS Group
XXIA

UBS Group’s Ixia XXIA Stock Holding History

UBS Group’s Portfolio XXIA Stock Details XXIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,675
Closed -$52K – 8382
2017
Q1 		$52K Buy
2,675
+923
+53% +$17.3K ﹤0.01% 5508
2016
Q4 		$28K Sell
1,752
-4,982
-74% -$68.9K ﹤0.01% 6302
2016
Q3 		$84K Buy
6,734
+5,129
+320% +$58.7K ﹤0.01% 5100
2016
Q2 		$16K Sell
1,605
-4,328
-73% -$44.5K ﹤0.01% 6487
2016
Q1 		$75K Buy
5,933
+3,934
+197% +$41.7K ﹤0.01% 5186
2015
Q4 		$25K Buy
1,999
+73
+4% +$998 ﹤0.01% 6537
2015
Q3 		$28K Sell
1,926
-1,381
-42% -$19.7K ﹤0.01% 6382
2015
Q2 		$41K Buy
3,307
+1,807
+120% +$22.5K ﹤0.01% 6188
2015
Q1 		$18K Buy
1,500
+94
+7% +$1.04K ﹤0.01% 7115
2014
Q4 		$16K Buy
+1,406
New +$13.8K ﹤0.01% 7987

Other funds holding XXIA

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

UBS Group's XXIA Position: Q2 2017 in Review

UBS Group sold out of Ixia (XXIA) in Q2 2017, closing a stake of 2,675 shares — an estimated $52K sold.

UBS Group first reported a position in XXIA in Q4 2014 and held it in 10 quarters. The position peaked at $84K in Q3 2016. 1 fund tracked by Wall St. Rank holds XXIA as of Q2 2017.

  • UBS Group reported no remaining Ixia position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 2,675 Ixia shares in Q2 2017, an estimated $52K.
  • UBS Group first reported a position in Ixia in Q4 2014 and held it in 10 quarters.
  • UBS Group's Ixia position peaked at $84K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ixia as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.